COMMUNIQUÉS West-GlobeNewswire

Cabaletta Bio Expands Management Team with Appointment of Brian Stalter as General Counsel
05/09/2019
Mr. Stalter joins Cabaletta with more than 20 years of general corporate and deal-making experience in small biotech and large pharma organizations PHILADELPHIA, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc., a [...]
Generex Announces Webcast
05/09/2019
CEO Joe Moscato’s Presentation at the H.C. Wainwright 21 st ANNUAL GLOBAL INVESTMENT CONFERENCE to be Webcast by Wall Street Webcasting Monday September 9, 2019 3:25 PM MIRAMAR, Fla., Sept. 05, 2019 (GLOBE NEWSWIRE) -- [...]
BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements
05/09/2019
MELVILLE, N.Y., Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at a special meeting of [...]
Precipio and University of Pennsylvania Enter into Joint Collaboration Agreement for Pathology Diagnostics
05/09/2019
First cases already diagnosed and reported by Penn expert pathologists NEW HAVEN, Conn., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Specialty Diagnostics company Precipio, Inc . ( NASDAQ: PRPO ), announced today a major [...]
BridgeBio Pharma expands its research into neuromuscular disease to include Limb-Girdle Muscular Dystrophy Type 2 (LGMD2i) with new subsidiary ML Bio Solutions
05/09/2019
Provides BridgeBio with leading scientific expertise to develop oral small molecule therapy for LGMD2i CHARLOTTE, N.C. and SAN FRANCISCO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today [...]
Oasmia publishes its annual report and adjusts accounts due to write-downs - auditors do not recommend former board to be granted discharge from liability
05/09/2019
Oasmia Pharmaceutical AB's annual report for the fiscal year 2018/2019 is now available on the company's website www.oasmia.com . Compared to the year-end report, which was published on June 28, the financial statements [...]
Media Advisory: JDRF Brings Together Pickering Community, Researcher, and Elected Officials to Discuss Affordable Access to Life-Changing Technologies for type 1 diabetes
05/09/2019
PICKERING, Ontario, Sept. 05, 2019 (GLOBE NEWSWIRE) -- On Thursday, September 12, JDRF Canada will host a community forum to address the need for access to affordable type 1 diabetes (T1D) technologies for the more than [...]
ProLynx announces publication and initiation of patient recruitment for a trial of once-monthly treatment of diabetes in cats
05/09/2019
SAN FRANCISCO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Today, ProLynx announced publication of data supporting therapy of Type 2 diabetes in cats with PLX039, a GLP-1 receptor agonist that can be administered once every [...]
La Jolla Pharmaceutical Company to Present at the 21st Annual H.C. Wainwright Global Investment Conference
05/09/2019
SAN DIEGO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
athenahealth Welcomes Paul Brient as Chief Product Officer
05/09/2019
Former PatientKeeper CEO and Industry Innovator to Drive Product Strategy for Healthcare IT Pioneer WATERTOWN, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- athenahealth, Inc., a leading provider of network-enabled services [...]
HearAtLast Holdings Acquires 100% of Fast Growing Canadian Start-up Crystal Clear Audio
05/09/2019
LAS VEGAS, NV, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- HearAtLast Holdings, Inc. (OTC:HRAL) , a holding company currently involved in restructuring and expanding its business model, revenue and asset base [...]
AMAG Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
05/09/2019
WALTHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2019. Bill Heiden, president and [...]
Forward Pharma to Participate in the Fall Investor Summit in New York
05/09/2019
COPENHAGEN, Denmark, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fall Investor Summit [...]
Tula Health Closes $2.6 Million Seed Round to Develop Personalized Digital Health Platform
05/09/2019
KAYSVILLE, Utah, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Tula Health, Inc, a transformative personalized digital health platform that continuously and noninvasively monitors blood glucose and key health metrics through its [...]
Aeglea BioTherapeutics to Present at 21st Annual H.C. Wainwright Global Investment Conference
05/09/2019
Live Webcast Scheduled for 5:30 p.m. ET on Monday, September 9 AUSTIN, Texas, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that engineers next- [...]
Aclaris Therapeutics Announces New Strategic Direction
05/09/2019
Completion of Strategic Review and Refocusing of Resources on Immuno-Inflammatory Development Pipeline Actively Seeking a Commercialization Partner for RHOFADE® (oxymetazoline hydrochloride) cream, 1% Actively Exploring [...]
INmune Bio to Present at the H.C. Wainwright 21st Annual Healthcare Conference on Tuesday, September 10th at 2:10 p.m. ET
05/09/2019
LA JOLLA, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB ), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is pleased [...]
Fortress Biotech to Present at September 2019 Investor Conferences
05/09/2019
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]
Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
05/09/2019
NEW YORK, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing [...]

Pages